Glass House Brands Inc. (GLAS): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$181.98M

Year ended 2025-12-31

+28.9%

3-year compound annual growth

2020-12-31 Revenue (USD) 2025-12-31

Period ended	Revenue	Change YoY	Source filing
2025-12-31	$181.98M	-9.4%	2026-03-24, From 2025-01-01
2024-12-31	$200.90M	+24.9%	2026-03-24, From 2024-01-01
2023-12-31	$160.84M	+89.5%	2025-03-25, From 2023-01-01
2022-12-31	$84.87M	+34.3%	2024-04-02, From 2022-01-01
2021-12-31	$63.19M	n/c	2024-04-02, From 2021-01-01
2020-12-31	$48.26M	n/a	2022-04-01, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
Glass House Brands Inc. (GLAS)	2025-12-31	$181.98M	-9.4%
biote Corp. (BTMD)	2025-12-31	$192.22M	-2.5%
Marimed Inc. (MRMD)	2025-12-31	$159.83M	+1.3%
Cronos Group Inc. (CRON)	2025-12-31	$146.59M	+24.6%
Natural Alternatives International Inc (NAII)	2026-06-30	$142.51M	+9.7%
Niagen Bioscience, Inc. (NAGE)	2025-12-31	$129.42M	+29.9%
Jushi Holdings Inc. (JUSH)	2025-12-31	$262.91M	+2.1%
Mannatech Inc (MTEX)	2025-12-31	$108.04M	-8.3%
Fitlife Brands, Inc. (FTLF)	2025-12-31	$81.46M	+26.4%

Compare GLAS, BTMD, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗